Fremanezumab Enhances Sleep Quality in Chronic Migraine Patients

Research Summary

A recent study published in Clinical Neurology and Neurosurgery explored the impact of fremanezumab on sleep quality in chronic migraine patients over six months. Chronic migraine sufferers often experience sleep disturbances, and this research involved 82 patients and 80 healthy controls. Using the Pittsburgh Sleep Quality Index (PSQI), researchers found that migraine patients had significantly worse sleep quality than controls. Notably, fremanezumab, administered monthly, improved both global PSQI scores and certain subscores. Poor sleep quality was linked to higher anxiety, depression, and headache impact scores, particularly in women, older adults, and those with higher BMI. Fremanezumab showed a significant positive effect on sleep quality in these patients.

Study Details

📄 Title: Quality of sleep in chronic migraine patients treated with fremanezumab - 6 months follow-up.

👥 Research Team: Stojanov A, Stojanov J, Djordjevic G

📚 Published In: Clin Neurol Neurosurg

📅 Publication Date: 2025 Nov 24

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.